We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 251 results
  1. Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis

    Background

    Newborn screening (NBS) for cystic fibrosis (CF) not only identifies infants with a diagnosis of CF, but also those with an uncertain...

    Chee Y. Ooi, Rosie Sutherland, ... Tanja Gonska in BMC Pediatrics
    Article Open access 22 October 2019
  2. Evaluation of specificity and sensitivity of IRT/IRT protocol in the cystic fibrosis newborn screening program: 6-year experience of three tertiary centers

    We aimed to evaluate cutoff values of immunoreactive trypsinogen (IRT)/IRT and determine relationship between IRT values and clinical characteristics...

    Tugba Ramasli Gursoy, Pelin Asfuroglu, ... Deniz Acican in European Journal of Pediatrics
    Article 24 December 2022
  3. Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present

    Background

    Cystic fibrosis (CF) is a life-threatening disease affecting about 1:3000 newborns in Caucasian populations. The introduction of newborn...

    Matteo Botti, Vito Terlizzi, ... Giovanni Taccetti in Italian Journal of Pediatrics
    Article Open access 06 January 2021
  4. Comparison of refugee patients with cystic fibrosis and their counterpart children from Turkey during the war

    Since the outbreak of the Syrian civil war in 2011, the population of Arab refugees in Turkey has rapidly increased. While cystic fibrosis (CF) is...

    Aslı İmran Yılmaz, Sevgi Pekcan, ... Ayşe Tana Aslan in European Journal of Pediatrics
    Article Open access 24 January 2024
  5. Abnormal biochemical indicators of neonatal inherited metabolic disease in carriers

    Background

    Traditional biochemical screening for neonatal inherited metabolic diseases has high false-positive rates and low positive predictive...

    Fang Guo, Lingna Zhou, ... Zhiwei Liu in Orphanet Journal of Rare Diseases
    Article Open access 04 April 2024
  6. Cystic fibrosis and alpha-1 antitrypsin deficiency: case report and review of literature

    Background

    This case report describes a child born with both cystic fibrosis (CF) and alpha-1 antitrypsin deficiency (A1ATD). Both are autosomal...

    Evi Jaspers, Ine Van Dijck, ... Marijke Proesmans in BMC Pediatrics
    Article Open access 03 May 2022
  7. Integrated diagnostics

    Background

    Integrated diagnostics is increasingly gaining scientific traction as it promises to address several challenges currently facing diagnostic...

    Verena Haselmann, Stefan O. Schoenberg, ... Matthias F. Froelich in Die Radiologie
    Article 12 July 2022
  8. Cystic fibrosis and CFTR-related disorder with electrolyte imbalance at diagnosis: clinical features and outcome in an Italian cohort

    There is limited information available on the clinical data, sweat test trends, and outcomes of individuals with cystic fibrosis (CF) who present...

    Vito Terlizzi, Rita Padoan, ... Donatello Salvatore in European Journal of Pediatrics
    Article 19 September 2023
  9. Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract in Cystic Fibrosis

    Purpose of Review

    To discuss all the various motility disorders impacting people with Cystic Fibrosis (PwCF) and provide diagnostic and management...

    Dhiren Patel, Folashade Jose, ... Baha Moshiree in Current Gastroenterology Reports
    Article 07 December 2023
  10. The Intestinal Microbiome and Cystic Fibrosis Transmembrane Conductance Regulator Modulators: Emerging Themes in the Management of Gastrointestinal Manifestations of Cystic Fibrosis

    Purpose of Review

    While commonly associated with pulmonary manifestations, cystic fibrosis (CF) is a systemic disease with wide-ranging effects on the...

    Daniel B. Karb, Linda C. Cummings in Current Gastroenterology Reports
    Article 27 August 2021
  11. Diagnosis of cystic fibrosis: a high heterogeneity of symptoms and genotypes in a Brazil population

    Introduction

    In highly multiracial populations with inadequate newborn screening, knowledge of the various phenotypic presentations of Cystic Fibrosis...

    Daniela Gois Meneses, Fábia Regina dos Santos, ... Ricardo Queiroz Gurgel in BMC Pediatrics
    Article Open access 01 July 2024
  12. Point of care lung ultrasound in preschool children with cystic fibrosis: a case-controlled, prospective, pilot study

    Aims

    Respiratory complications in Cystic Fibrosis (CF) are still the leading cause of death nowadays in these patients. High-Resolution Computed...

    Antonio Alessandro Crispino, Anna Maria Musolino, ... Daniela Concolino in Journal of Ultrasound
    Article 19 January 2024
  13. Repeated Stimulation of Toll-Like Receptor 2 and Dectin-1 Induces Chronic Pancreatitis in Mice Through the Participation of Acquired Immunity

    Background

    Stimulation of Toll-like receptor 3 (TLR3) induces autoimmune-mediated pancreatitis in susceptible mice, whereas stimulation of TLR4 causes...

    Masahiro Takeo, Akiyoshi Nishio, ... Kazuichi Okazaki in Digestive Diseases and Sciences
    Article 23 August 2021
  14. Study Designs: Diagnostic Studies

    Diagnostic tests are evolving with betterment of technology, quest for patient safety with less invasive medicine, and evolution of new diseases. It...

    Nitin Dhochak, Rakesh Lodha in Indian Pediatrics
    Article 20 April 2021
  15. Elevated sweat chloride test: is it always cystic fibrosis?

    Background

    The sweat chloride test (ST) is the gold standard for cystic fibrosis (CF) diagnosis in symptomatic patients, within the newborn screening...

    C. Cimbalo, A. Tosco, ... V. Raia in Italian Journal of Pediatrics
    Article Open access 14 May 2021
  16. Racially equitable diagnosis of cystic fibrosis using next-generation DNA sequencing: a case report

    Background

    Cystic Fibrosis (CF) is one of the most prevalent autosomal recessive inherited disease in Caucasians. Rates of CF were thought to be...

    Bennett O. V. Shum, Glenn Bennett, ... R. Kishore Kumar in BMC Pediatrics
    Article Open access 31 March 2021
  17. Impact of newborn screening for cystic fibrosis on clinical outcomes of pediatric patients: 10 years’ experience in Lodz Voivodship

    Background

    Cystic Fibrosis newborn screening (CFNBS) is the optimal method to diagnose the disease during the asymptomatic period. The aim of the...

    M. Olszowiec-Chlebna, E. Mospinek, J. Jerzynska in Italian Journal of Pediatrics
    Article Open access 09 April 2021
  18. Carrier screening and PGT for an autosomal recessive monogenic disorder: insights from virtual trials

    Purpose

    To assess the costs and benefits of carrier screening and preimplantation genetic testing (PGT) for recessive autosomal monogenic disorders...

    Article 19 January 2022
  19. Communicating cystic fibrosis newborn screening results to parents

    The way results of cystic fibrosis (CF) newborn screening are communicated to parents is critical yet is done differently across the globe. We...

    L. Seddon, K. Dick, ... I. M. Balfour-Lynn in European Journal of Pediatrics
    Article Open access 17 October 2020
  20. Molecular analysis of CFTR gene mutations among Iraqi cystic fibrosis patients

    Background

    Cystic fibrosis (CF) is an autosomal recessive multisystem disease that results from mutation(s) of the cystic fibrosis transmembrane...

    Asal Gailan Abdul-Qadir, Bassam Musa Al-Musawi, ... Saad Abdul-Baqi Al-Omar in Egyptian Journal of Medical Human Genetics
    Article Open access 11 May 2021
Did you find what you were looking for? Share feedback.